Surveillance Data 2009-2013
Most Common Enteroviruses reported in the U.S., 2009-2013
Enterovirus | Number of Positive Specimens |
---|---|
1 Coxsackievirus A6 | 12.3% of specimens |
2 Human Parechovirus 3 | 12.3% of specimens |
3 Echovirus 11 | 7.9% of specimens |
4 Echovirus 18 | 5.6% of specimens |
5 Coxsackievirus A9 | 5.1% of specimens |
6 Coxsackievirus B4 | 5% of specimens |
7 Echovirus 30 | 5% of specimens |
Detections were reported in 45 states and Puerto Rico. The U.S. Census Region most often named as the patients’ location was the Midwest (40.0% of the 2,271 patients for whom state or territory was known), followed by the South (29.1%).
From 2009 through 2013, NESS received reports of 2,724 specimens that were obtained from 2,532 patients for enterovirus (EV) and human parechovirus (HPeV) testing; the number of specimens reported each year ranged from 392 in 2011 to 870 in 2012. The most commonly reported specimen types among those for which type was known (77.5% of 2,724 specimens) were:
- cerebrospinal fluid (31.6%),
- throat/nasopharyngeal swab (29.8%),
- stool/rectal swab (13.5%),
- tissue culture isolates (7.5%), and
- lesion swab/scraping (3.7%).
Of the 1,763 patients for whom gender was reported, 56.2% were male.
Age was reported for 1,763 patients. The age groups most widely represented were children younger than 1 year of age (687 [39.0%]) and children between 1 and 4 years of age (387 [22.0%]).
For more information about the most recent enterovirus data, see CDC MMWR Enterovirus and Human Parechovirus Surveillance – United States, 2009 – 2013.
Top of PageSurveillance Data by Month
Number of enteroviruses and parechoviruses reported to NESS by type and month of specimen collection.
Type | 2016 | 2015 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb | Jan | Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | |
Coxsackievirus A2 | . | . | . | . | . | . | . | . | 1 | . | . | . |
Coxsackievirus A4 | . | . | . | . | . | . | . | . | 1 | . | 1 | . |
Coxsackievirus A5 | . | . | . | . | 1 | . | 2 | . | . | 1 | . | . |
Coxsackievirus A6 | . | 1 | . | 3 | 6 | 3 | 3 | 4 | . | . | . | 1 |
Coxsackievirus A8 | . | . | . | . | . | . | . | . | . | 1 | . | . |
Coxsackievirus A9 | . | . | . | . | 1 | 2 | 7 | 5 | . | . | . | 1 |
Coxsackievirus A10 | . | . | . | . | . | . | 1 | . | . | . | . | . |
Coxsackievirus A16 | . | . | 1 | . | 3 | 2 | 1 | 1 | . | . | 1 | . |
Coxsackievirus B1 | . | . | . | . | 1 | . | . | . | . | . | . | . |
Coxsackievirus B2 | . | . | . | . | . | . | . | 1 | 1 | . | . | . |
Coxsackievirus B3 | . | . | . | . | 2 | 1 | 1 | 1 | . | . | . | . |
Coxsackievirus B4 | . | . | . | 4 | 2 | 2 | 1 | 2 | . | . | 1 | . |
Coxsackievirus B5 | . | . | . | 1 | 1 | 2 | . | . | 1 | . | . | 1 |
Echovirus 3 | . | . | . | 1 | 3 | 6 | 5 | 4 | . | . | . | . |
Echovirus 5 | . | . | . | . | . | . | 1 | . | . | . | . | . |
Echovirus 6 | . | . | . | . | . | 2 | 3 | 2 | 1 | . | . | . |
Echovirus 7 | . | . | . | . | 1 | . | . | . | . | . | . | . |
Echovirus 9 | . | . | . | . | 1 | 1 | . | 12 | . | . | . | . |
Echovirus 11 | . | . | . | . | . | . | 3 | 1 | . | . | . | . |
Echovirus 16 | . | . | . | . | . | 1 | . | . | . | . | . | . |
Echovirus 18 | . | . | . | 1 | 1 | 7 | 13 | 14 | 1 | . | 2 | . |
Echovirus 20 | . | . | . | . | 1 | . | . | . | . | . | . | . |
Echovirus 25 | . | 1 | . | 2 | 2 | 1 | 2 | . | . | . | 1 | . |
Echovirus 30 | . | . | . | 2 | 10 | 18 | 10 | 9 | 18 | 2 | 18 | . |
Human Parechovirus1 | . | 4 | . | . | 2 | . | 1 | 1 | . | . | . | . |
Human Parechovirus3 | . | . | . | . | 2 | . | 3 | . | . | . | . | . |
Human Parechovirus4 | . | . | . | . | . | . | 1 | . | . | . | . | . |
Human Parechovirus6 | . | . | 1 | . | . | . | . | . | . | . | . | . |
Enterovirus Type Unknown | . | . | 4 | . | 2 | 2 | 13 | 5 | 3 | 1 | 4 | . |
The number of detected types in a given month may change depending upon the latest laboratory reports.
Top of Page- Page last reviewed: March 11, 2016
- Page last updated: March 11, 2016
- Content source: